Accession Number: | 0001213900-20-020143 |
Date: | 2020-08-03 |
Issuer: | RELMADA THERAPEUTICS, INC. (RLMD) |
Original Submission Date: |
CASAMENTO CHARLES J
C/O RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR
NEW YORK, CA 10022
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-08-03 | S | 3,000 | d | $35.74 | 34,000 | direct | ||
COMMON STOCK | 2020-08-03 | 0 | $0.00 | 21,484 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 29, 2020. the range of prices for the transaction reported on this line was $35.40 to $36.69. the average weighted price was $35.7378. the reporting person will provide, upon request by the sec, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
f2 | represents shares of common stock held by a family trust. mr. casamento disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that mr. casamento is the beneficial owner of such securities for purposes of section 16 of the securities and exchange act of 1934, or for any other purpose. |